Clinical Trial Update: Fipamezole in Neurogenic Orthostatic Hypotension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on fipamezole for symptomatic neurogenic orthostatic hypotension, with associated conditions including Parkinson's disease and mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Neurogenic Orthostatic Hypotension
• Parkinson Disease

Drugs mentioned

• Fipamezole

Snippet

Sponsor: Juvantia Pharma Ltd | Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH), Parkinson's Disease | Phase 2 | Status: UNKNOWN